SCHEMBL11301119

SCHEMBL11301119

COC(=O)c1ccc(N(C(C)Cc2ccccc2)C2CCNC2=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ HSP90AA1 P07900 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ RAB9A P51151 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ ROCK2 O75116 1/20 0.38
▸ UBE2M P61081 1/20 0.37
▸ DCUN1D1 Q96GG9 1/20 0.37
▸ OPRD1 P41143 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ F11 P03951 1/20 0.37
▸ KLKB1 P03952 1/20 0.37
▸ MGLL Q99685 1/20 0.37
▸ CCR5 P51681 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11301136 0.79 ROCK2 (0.42) MAPTALDH1A1SMN1; SMN2HSP90AA1HTT
SCHEMBL11295039 0.72 PSEN1 (0.40) SMN1; SMN2KMT2ATSHR
SCHEMBL11299441 0.71 MAPK14 (0.37) MAPTMEN1KMT2AOPRD1TSHR
SCHEMBL11296532 0.69 SLC6A3 (0.40) MAPTALDH1A1SMN1; SMN2RAB9AMEN1
SCHEMBL10822415 0.69 CA1 (0.49) MAPTSMN1; SMN2HTTCA1CA2
SCHEMBL10822413 0.69 CA1 (0.49) MAPTSMN1; SMN2HTTCA1CA2
SCHEMBL11296506 0.69 ALOX15 (0.44) ALDH1A1HTTRAB9ANPC1TSHR
SCHEMBL23176754 0.68 HPGD (0.52) MAPTALDH1A1SMN1; SMN2CA1CA2
SCHEMBL11300775 0.68 HDAC1 (0.50) —
SCHEMBL11301393 0.67 ALOX15 (0.56) MAPTALDH1A1SMN1; SMN2HTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback